X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-29-2023-18805.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-8-2023-15780.pdf
https://www.fiercepharma.com/pharma/cingulate-posts-clinical-data-once-daily-triple-release-anxiety-tablet
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-9-2021-1623238294.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-2-2020-1599053980.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210907
https://www.moneycontrol.com/news/business/unichem-labs-gets-usfda-nod-to-market-anxiety-disorder-tablets-4644041.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208972
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208829
https://www.pharmacompass.com/pdf/news/emcure-pharms-generic-buspirone-hydrochloride-5-15mg-approved-in-us-for-anxiety-1443179839.pdf
Market Place
Share 
